Current Report Filing (8-k)
21 December 2022 - 9:22AM
Edgar (US Regulatory)
0001538217
false
0001538217
2022-12-20
2022-12-20
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
DC 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported) December 20, 2022 (December 16, 2022)
SRAX,
INC.
(Exact
name of registrant as specified in its charter)
Delaware |
|
001-37916 |
|
45-2925231 |
(State
or other jurisdiction
of
incorporation or organization) |
|
(Commission
File
Number) |
|
(I.R.S.
Employer
Identification
No.) |
2629
Townsgate Road #215, Westlake Village, CA |
|
91362 |
(Address
of principal executive offices) |
|
(Zip
Code) |
Registrant’s
telephone number, including area code: |
|
(323)
694-9800 |
not
applicable
(Former
name or former address, if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions (see General Instruction A.2. below):
☐ |
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
|
☐ |
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
|
☐ |
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
|
☐ |
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Title
of Class |
|
Trading
Symbol |
|
Name
of Each Exchange on Which Registered |
Class
A Common stock |
|
SRAX |
|
NASDAQ
Global Market |
Indicate
by check mark whether the registrant is an emerging growth company as defined in in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company ☐
If
an emerging growth company, indicate by checkmark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item
8.01 Other Events.
On
December 16, 2022, SRAX, Inc. (the “Company”) received a determination from the Nasdaq
Hearings Panel (the “Panel”) granting the Company’s request for the continued listing of its Class A Common Stock on
The Nasdaq Stock Market (“Nasdaq”), subject to the Company evidencing compliance with Nasdaq’s filing requirement,
as set forth in Nasdaq Listing Rule 5250(c)(1), on or before February 28, 2023, and certain other conditions. The Company is working
to file its delinquent periodic reports with the Securities and Exchange Commission as soon as practicable and thereby timely evidence
compliance with the terms of the Panel’s decision. There can be no assurances however that the Company will be able to do so.
Cautionary
Statement Regarding Forward Looking Statements
This
communication contains “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of
1995, including, without limitation, statements related to the anticipated filing of certain of the Company’s period reports with
the SEC, and other statements that are not historical facts. Any statements contained in this communication that are not statements of
historical fact may be deemed to be forward-looking statements. Forward-looking statements may be identified by the use of words referencing
future events or circumstances such as “expect,” “intend,” “plan,” “anticipate,” “believe,”
“will,” and similar expressions and their variants. These forward-looking statements are based upon the Company’s current
expectations. Forward-looking statements involve risks and uncertainties. The Company’s actual results and the timing of events
could differ materially from those anticipated in such forward-looking statements as a result of these risks and uncertainties.
Item
9.01 Financial Statements and Exhibits
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report on Form 8-K to be signed on its
behalf by the undersigned hereunto duly authorized.
Date: |
December 20, 2022 |
SRAX, Inc. |
|
|
|
|
|
|
|
/s/ Christopher
Miglino |
|
|
By: |
Christopher Miglino |
|
|
|
Chief Executive Officer |
INDEX
OF EXHIBITS
SRAX (NASDAQ:SRAX)
Historical Stock Chart
From Jan 2025 to Feb 2025
SRAX (NASDAQ:SRAX)
Historical Stock Chart
From Feb 2024 to Feb 2025